Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Pharmacyte Biotech Inc (NQ: PMCB )

2.500 -0.190 (-7.06%)
Streaming Delayed Price Updated: 1:00 PM EST, Nov 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 260,276
Open 2.570
Bid (Size) 2.500 (30)
Ask (Size) 2.600 (99)
Prev. Close 2.690
Today's Range 2.490 - 2.580
52wk Range 2.250 - 9.980
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
PharmaCyte Biotech Announces Cell Encapsulation Technology Material Does Not Cause Skin Irritation
PharmaCyte Biotech announces that its clinical trial product material does not cause skin irritation passing another biocompatibility test. 
From Business Wire News Releases
PharmaCyte Biotech Announces Encapsulation Material Does Not Alter Cellular DNA
PharmaCyte Biotech announces that its encapsulation material does not alter cellular DNA. 
From Business Wire News Releases

Performance

YTD
-17.49%
-17.49%
1 Month
-12.59%
-12.59%
3 Month
-28.37%
-28.37%
6 Month
-17.49%
-17.49%
1 Year
-17.49%
-17.49%

More News

Read More
PharmaCyte Biotech Releases More Positive Results From FDA-Required Biocompatibility Tests
From Business Wire News Releases
PharmaCyte Biotech Announces Positive Results of Biocompatibility Study for FDA
From Business Wire News Releases
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Tags ACER AVDL VALN
From Benzinga
3 Penny Stocks Waiting on FDA Approval for Rocket Fuel
Tags Penny Stocks SESN PMCB
From InvestorPlace
PharmaCyte Biotech to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
From Business Wire News Releases
PharmaCyte Biotech Establishes 18-Month Shelf Life for Clinical Trial Product in Ongoing Stability Study
From Business Wire News Releases
Why Are PharmaCyte Shares Moving Higher On Thursday?
Tags News Movers Market News
From Benzinga
PharmaCyte Biotech Expands Product Pipeline to Include Diabetes and Malignant Ascites Following $90-Million Capital Raise
From Business Wire News Releases
7 Penny Stocks Waiting on The FDA for Rocket Fuel
Tags Market News VBIV VTVT
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.